0

537253

SUNLOC

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUNIL HEALTHCARE LTD Share Price Today

Investment Returns

Over 1 Month 2.58% Over 3 Months -2.15% Over 6 Months -9.14% Over 1 Year -20.50%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SUNIL HEALTHCARE LTD fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 74.00
  • P/E Ratio (TTM) -13.53
  • Beta 0.26
  • Book Value / share 49.83
  • Return on equity 0.51%
  • EPS (TTM) 3.79
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -6.82
info icon alternate text

SUNIL HEALTHCARE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 19.72
Operating Expense 19.77
Net Profit -6.82
Net Profit Margin (%) -34.58
Earnings Per Share (EPS) -6.65
EBITDA -6.10
Effective Tax Rate (%) 26.50
Particulars DEC 2025 (Values in Cr)
Revenue 21.84
Operating Expense 21.49
Net Profit 0.44
Net Profit Margin (%) 2.01
Earnings Per Share (EPS) 0.43
EBITDA 3.98
Effective Tax Rate (%) 37.14
Particulars SEP 2025 (Values in Cr)
Revenue 23.52
Operating Expense 22.63
Net Profit 0.79
Net Profit Margin (%) 3.35
Earnings Per Share (EPS) 0.77
EBITDA 4.14
Effective Tax Rate (%) 28.18
Particulars JUN 2025 (Values in Cr)
Revenue 22.64
Operating Expense 22.46
Net Profit 0.29
Net Profit Margin (%) 1.28
Earnings Per Share (EPS) 0.28
EBITDA 3.51
Effective Tax Rate (%) 29.26
Particulars MAR 2025 (Values in Cr)
Revenue 21.20
Operating Expense 21.52
Net Profit 0.25
Net Profit Margin (%) 1.17
Earnings Per Share (EPS) 0.25
EBITDA 3.42
Effective Tax Rate (%) -44.44
Particulars MAR 2026 (Values in Cr)
Revenue 87.72
Operating Expense 86.35
Net Profit -5.30
Net Profit Margin (%) -6.04
Earnings Per Share (EPS) -5.17
EBITDA 5.52
Effective Tax Rate (%) 25.14
Particulars MAR 2025 (Values in Cr)
Revenue 83.42
Operating Expense 84.36
Net Profit 0.21
Net Profit Margin (%) 0.25
Earnings Per Share (EPS) 0.20
EBITDA 13.21
Effective Tax Rate (%) 48.78
Particulars MAR 2024 (Values in Cr)
Revenue 89.69
Operating Expense 97.27
Net Profit -2.11
Net Profit Margin (%) -2.35
Earnings Per Share (EPS) -2.06
EBITDA 8.98
Effective Tax Rate (%) 26.73
Particulars MAR 2023 (Values in Cr)
Revenue 111.83
Operating Expense 103.70
Net Profit 6.98
Net Profit Margin (%) 6.24
Earnings Per Share (EPS) 6.80
EBITDA 20.93
Effective Tax Rate (%) 28.48
Particulars MAR 2022 (Values in Cr)
Revenue 116.37
Operating Expense 108.36
Net Profit 6.78
Net Profit Margin (%) 5.82
Earnings Per Share (EPS) 6.61
EBITDA 19.37
Effective Tax Rate (%) 29.15
Particulars MAR 2025 (Values in Cr)
Book Value / Share 49.09
ROE % -2.80
ROCE % 4.39
Total Debt to Total Equity 1.27
EBITDA Margin 13.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 49.71
ROE % -3.44
ROCE % 3.07
Total Debt to Total Equity 0.94
EBITDA Margin 10.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 51.73
ROE % 13.35
ROCE % 15.58
Total Debt to Total Equity 0.68
EBITDA Margin 18.71
Particulars MAR 2022 (Values in Cr)
Book Value / Share 45.84
ROE % 14.63
ROCE % 14.45
Total Debt to Total Equity 0.92
EBITDA Margin 16.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 39.76
ROE % -1.50
ROCE % 5.04
Total Debt to Total Equity 1.12
EBITDA Margin 12.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 55.51
ROE % 0.51
ROCE % 5.55
Total Debt to Total Equity 1.13
EBITDA Margin 15.97
Particulars MAR 2024 (Values in Cr)
Book Value / Share 55.40
ROE % -3.65
ROCE % 2.62
Total Debt to Total Equity 0.85
EBITDA Margin 10.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 57.32
ROE % 12.62
ROCE % 15.00
Total Debt to Total Equity 0.61
EBITDA Margin 18.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 50.56
ROE % 13.99
ROCE % 14.07
Total Debt to Total Equity 0.84
EBITDA Margin 16.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 44.01
ROE % 0.71
ROCE % 5.90
Total Debt to Total Equity 1.07
EBITDA Margin 13.14
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.08
Total Assets 161.94
Total Liabilities 161.94
Total Equity 67.06
Share Outstanding 1
Price to Book Ratio 1.18
Return on Assets (%) -0.87
Return on Capital (%) -1.04
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.61
Total Assets 158.49
Total Liabilities 158.49
Total Equity 68.21
Share Outstanding 1
Price to Book Ratio 1.11
Return on Assets (%) -1.12
Return on Capital (%) -1.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.93
Total Assets 120.79
Total Liabilities 120.79
Total Equity 55.99
Share Outstanding 1
Price to Book Ratio 0.99
Return on Assets (%) 5.53
Return on Capital (%) 7.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.45
Total Assets 109.69
Total Liabilities 109.69
Total Equity 49.95
Share Outstanding 1
Price to Book Ratio 1.41
Return on Assets (%) 5.85
Return on Capital (%) 7.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.27
Total Assets 120.56
Total Liabilities 120.56
Total Equity 43.71
Share Outstanding 1
Price to Book Ratio 0.52
Return on Assets (%) -0.52
Return on Capital (%) -0.69
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.07
Total Assets 168.21
Total Liabilities 168.21
Total Equity 73.65
Share Outstanding 1
Price to Book Ratio 1.18
Return on Assets (%) 0.12
Return on Capital (%) 0.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.58
Total Assets 163.89
Total Liabilities 163.89
Total Equity 74.04
Share Outstanding 1
Price to Book Ratio 1.11
Return on Assets (%) -1.28
Return on Capital (%) -1.5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.36
Total Assets 126.07
Total Liabilities 126.07
Total Equity 61.72
Share Outstanding 1
Price to Book Ratio 0.99
Return on Assets (%) 5.53
Return on Capital (%) 7.2
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.22
Total Assets 112.18
Total Liabilities 112.18
Total Equity 54.78
Share Outstanding 1
Price to Book Ratio 1.41
Return on Assets (%) 6.04
Return on Capital (%) 7.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.77
Total Assets 123.56
Total Liabilities 123.56
Total Equity 48.07
Share Outstanding 1
Price to Book Ratio 0.52
Return on Assets (%) 0.22
Return on Capital (%) 0.28
Particulars MAR 2025 (Values in Cr)
Net Income -1.21
Cash from Operations 11.47
Cash from Investing -7.70
Cash from Financing -3.86
Net change in Cash -0.04
Free Cash Flow 20.90
Particulars MAR 2024 (Values in Cr)
Net Income -2.55
Cash from Operations -14.63
Cash from Investing -10.11
Cash from Financing 25.00
Net change in Cash -0.50
Free Cash Flow -4.17
Particulars MAR 2023 (Values in Cr)
Net Income 9.48
Cash from Operations 8.84
Cash from Investing -3.40
Cash from Financing -3.74
Net change in Cash 0.32
Free Cash Flow 13.04
Particulars MAR 2022 (Values in Cr)
Net Income 9.26
Cash from Operations 23.70
Cash from Investing -4.23
Cash from Financing -18.55
Net change in Cash -0.28
Free Cash Flow 32.74
Particulars MAR 2021 (Values in Cr)
Net Income -0.55
Cash from Operations 16.82
Cash from Investing -11.35
Cash from Financing -6.41
Net change in Cash -0.78
Free Cash Flow 23.66
Particulars MAR 2025 (Values in Cr)
Net Income 0.40
Cash from Operations 11.43
Cash from Investing -7.70
Cash from Financing -3.86
Net change in Cash -0.02
Free Cash Flow 20.86
Particulars MAR 2024 (Values in Cr)
Net Income -2.88
Cash from Operations -13.58
Cash from Investing -10.61
Cash from Financing 25.00
Net change in Cash 0.03
Free Cash Flow -3.12
Particulars MAR 2023 (Values in Cr)
Net Income 9.75
Cash from Operations 8.49
Cash from Investing -3.40
Cash from Financing -3.74
Net change in Cash -0.01
Free Cash Flow 12.69
Particulars MAR 2022 (Values in Cr)
Net Income 9.57
Cash from Operations 23.06
Cash from Investing -3.34
Cash from Financing -18.55
Net change in Cash -0.01
Free Cash Flow 32.10
Particulars MAR 2021 (Values in Cr)
Net Income 0.34
Cash from Operations 16.44
Cash from Investing -11.32
Cash from Financing -6.41
Net change in Cash -1.11
Free Cash Flow 23.28
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.45 62.45 12.89 122165.91 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.38 23.70 2.85 98.17 40.75 77.00
SHREE PACETRONIX LTD. 137.90 16.46 2.90 51.71 66.10 283.15
TRANSGENE BIOTEK LTD. 2.94 0.00 2.65 22.28 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.45 81.38 12.26 122165.91 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.94 0.00 -9.47 29.09 30.30 57.48
KOVAI MEDICAL CENTER & HO 5803.05 25.97 4.81 6348.54 5010.00 6725.00

SUNIL HEALTHCARE LTD shareholding pattern

Holding
26.36%
73.52%
0.1%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SUNIL HEALTHCARE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
72.21 3.23 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 66.10
  • 26 Days 64.10
  • 10 Days 64.90
  • 50 Days 64.00
  • 12 Days 64.70
  • 100 Days 65.30
  • 20 Days 64.20
  • 200 Days 68.50
62.33 PIVOT
First Support 60.97 First Resistance 63.67 Second Support 59.63 Second Resistance 65.03 Third Support 58.27 Third Resistance 66.37
RSI 50.46 ADX 8.59 MACD -0.19 Williams % R -57.33 Commodity Channel Index (CCI) 2.70
Date 2026-06-12 Week 121.00 Same Day 5.00 Month 291.00
1 Year 0.21 3 Year 0.58
Over 1 Month
2.58% down
Over 1 Year
-20.50% down
Over 3 Months
-2.15% down
Over 3 Years
1.04% down
Over 6 Months
-9.14% down
Over 5 Years
12.49% down

SUNIL HEALTHCARE LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sunil Healthcare Ltd?

Answer Field

Sunil Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 72.21 as on Jun 19 2026 03:30 PM.

What is the Market Cap of Sunil Healthcare Ltd Share?

Answer Field

The market cap of Sunil Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 74.00 as on Jun 19 2026 03:30 PM.

What is the 52 Week High and Low of Sunil Healthcare Ltd?

Answer Field

The 52 Week High and Low of Sunil Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 88.70 and ₹ 56.35.

What is 1 year return for Sunil Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -12.61%.

What is the P/E Ratio of Sunil Healthcare Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM the price-to-earnings (PE) ratio for Sunil Healthcare Ltd share is -13.53.

What is the PB ratio of Sunil Healthcare Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM, the price-to-book (PB) ratio for Sunil Healthcare Ltd share is 49.83.

How to Buy Sunil Healthcare Ltd Share?

Answer Field

You can trade in Sunil Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sunil Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Sunil Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sunil Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|